LCI 1461 (Dipyridamole 25 mg)
Pill imprint LCI 1461 has been identified as Dipyridamole 25 mg.
Dipyridamole is used in the treatment of radionuclide myocardial perfusion study; prosthetic heart valves - thrombosis prophylaxis and belongs to the drug classes cardiac stressing agents, platelet aggregation inhibitors. There is no proven risk in humans during pregnancy. Dipyridamole 25 mg is not subject to the Controlled Substances Act.
See also related documents.
- 25 mg
- Prescription only
Platelet aggregation inhibitors
silicon dioxide colloidal
FD&C Red No. 40
FD&C Yellow No. 6
|NDC Code||Manufacturer / Repackager|
|10135-0536||Marlex Pharmaceuticals Inc|
Note: Inactive ingredients may vary.
More about dipyridamole
- Other brands: Persantine
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.